NBIX

NASDAQNeurocrine Biosciences Inc
High Tide · 56Squeeze · Idle 23Neutral0 buys · $0Social · No data 0
$155.13
$-0.51 (-0.33%)
15-min delayed · Sep 8, 5:37 PMReal-time

Score summary

Strong Buy
Analyst Ratings
22Ratings
19 Buy3 Hold0 Sell
Tide Score
56
High Tide · stable · Top 34% of universe (3990)
Outlook54High Tide · stable · Top 45% of universe (3991)
Squeeze Score
23
Idle ·
  • Days to cover3.42
  • Short interest4.53% of float
  • Borrow rate26.08%
  • Short interest trend+0.16% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 2 super investors

Key statistics

Market Cap
$15.82B
52-week range
$123.10 – $185.50
26% from low
Day range
$155 – $160
Open $158.24
Volume
933k
vs 1.3M avg · 71%
P/E (TTM)
22.8
Fwd 13.0
Earnings
Oct 27
49d · est $1.99

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 22 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$210
22 Wall St 12-month targets
High
$249
Average
$202
Low
$160
$121$155$188$221$254HIGH$249MEDIAN$210LOW$160Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 72/100 Analyst Score (Strong Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 27 (post-market, est EPS $1.99) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.